Chargement en cours...
Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)
PURPOSE: Treatment options for patients with advanced HNSCC are scarce. This phase II study was conducted to evaluate the safety, tolerability, PK, and efficacy of dasatinib in this setting. EXPERIMENTAL DESIGN: Patients with recurrent and/or metastatic HNSCC after platinum-based therapy were treate...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3117018/ https://ncbi.nlm.nih.gov/pubmed/21523723 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25769 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|